The conference brought together patients and patient advocates with pharmaceutical industry professionals, hospital leaders, and technology experts to explore how emerging technologies such as AI, machine learning, virtual reality, and social media can be strategically leveraged to enhance patient engagement, education, and support. Participants will learn about the latest advancements in these technologies, showcase successful case studies, and discuss strategies for addressing trust, privacy, health equity, and regulatory compliance challenges. The conference aims to foster collaboration, knowledge-sharing, and networking among attendees to develop innovative, patient-centric solutions while examining the ethical implications and guidelines for responsible implementation of these technologies in healthcare. By the end of the conference, participants will be equipped with the knowledge and skills necessary to effectively leverage emerging technologies in their patient-centric initiatives, improving outcomes and experiences while navigating the policy and regulatory landscape.

Visit this page to see the full conference program and view the recordings using the links below.

See photos of this event and a summary of the highlights on this LinkedIn Post.

Register to DCI Network here to be alerted of new content and future events.

Description

Welcome Remarks:

Dr. Yuri Quintana, PhD, Chief, Division of Clinical Informatics, Department of Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School

Dr. Mark Zeidel, MD, Chief, Department of Medicine, Beth Israel Deaconess Medical Center

Dr. Charles Safran, MD, Professor Emeritus, Harvard Medical School

Description

The Future of Patient Engagement: Informed Patients Sharing the Work

"e-Patient Dave" deBronkart, Founding Co-chair, Society for Participatory Medicine and HL7 FHIR Patient Empowerment Workgroup

For far too long, patients have been relegated to the role of "humble supplicants," as BMJ editor Dr. Tessa Richards brilliantly stated. She was excluded from participating in the tumor board's discussions about treatments for her own cancer. In the past, "patient engagement" often amounted to simply persuading patients to unquestionably follow medical guidance within a paternalistic system, assuming that patients were incapable of handling the truth and would not know how to make decisions about their own care. But the times have changed. This keynote will call us to learn to listen to patients' voices and work with them as thinking co-producers. The key lesson to remember is that the future is unfolding before us, whether we acknowledge it or not.

Description

Panel 1: Patient Perspectives

Self-Advocating While Seeking a Medical Balance Quality of Life

Glenda Thomas, Advisory Council: Beth Israel Deaconess Medical Patient, Family, and Caregiver Advisory Council (PFAC), Massachusetts Rare Disease Advisory Council, UCB Myasthenia Gravis Patient Advisory Council, Alexion MG Patient Registry Advisory Board, Argenx MG Advocacy Leadership Council; New England MG Support Group Leader, Myasthenia Gravis (MG) Foundation of America; DCI Network Working Group 2 Steering Committee; Founder and CEO, nCeptive-Daily Money Manager (DMM)

Description

Keynote 3: The Other 50%: Navigating Preventative Cancer Screening For People Without A Primary Care Physician

Dr. Eric Perakslis, PhD, Chief Scientific and Data Officer, Pluto Health; Senior Vice President and Chief Technology Officer, IMIDomics

Approximately half of Americans lack a dedicated primary care doctor resulting in significant gaps in preventative and primary care for these populations. While it is well known that the many cancers are managed well if caught early, the incidence of people that have never had a mammogram, colonoscopy or lung cancer screening is highest in the most vulnerable subsets of our citizens. Despite the promise of digital health solutions to aid these populations, most digital-centric approaches have failed. In this talk, we will discuss hybrid ‘click-and-mortar’ approaches to preventative cancer care currently being piloted and will discuss the potential benefits and risks of hybrid digital preventative care.

Description

Panel 2: Innovative Healthcare Delivery

Bridging the Gaps: Leveraging AI to Ensure Continuity of Care from Hospital to Home

Dr. Amy Price, DPhil, Senior Research Scientist, Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine, Dartmouth College; BMJ Research Editor (Patient and Public Partnership)

Description

Panel 3: Future of Chatbots and Ambient AI

Designing and Testing an Evidence-Based Mental Health Chatbot using Generative Artificial Intelligence

Dr. Nicholas C. Jacobson, PhD, Assistant Professor, Biomedical Data Science and Psychiatry, Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College

Description

Panel 4: Future Approaches to Patient Engagement and Medication Information Access

FDA Digital Initiatives for Medication Information

Dr. Gideon Scott Gordon, PhD, Senior Health Informatics Officer, Office of Strategic Programs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration